FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
McKnight's Long-Term Care News7h
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Hosted on MSN1h
Pharma Stock Roundup: NVO's Obesity Study Failure, FDA Nod to PFE, LLY
Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...
Alaska Dispatch News17hOpinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Medscape16h
Taft and Pickwick: Sleep Apnea in the White House
This article presents evidence that he suffered from obstructive sleep apnea, manifested by excessive daytime somnolence, snoring, systemic hypertension and, perhaps, cognitive and psychosocial ...
New York Daily News16h
New York Daily News
Taxi jumps curb, slams into Christmas Day crowd outside Manhattan Macy’s on W. 34th St. A taxi cab jumped the curb and slammed into six pedestrians walking near Macy's on W. 34th St. and Sixth ...